Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-24-000123

Chief Executive Officer sold 11,091 shares at $42.75 ($474,140)

  • Chief Executive Officer acquired 22,691 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Goff Brian · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-08-08 Exercise or conversion : show line 1 in the form 10b5-1 +22,691 89,883 D
2024-08-08 Sale : show line 2 in the form 10b5-1 −11,091 $42.75 $474,140 78,792 D
Open-market sales · 11,091 sh · avg $42.75 · $474,140

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-08-08 Exercise or conversion : show line 3 in the form 10b5-1 Restricted stock units −22,691 22,691 D
Loading xslF345X05/wk-form4_1723497325.xml…